Search Results

November 17: Join our last Dr. GPCR Symposium of the year on GPCRs in Immunology and Oncology! Our confirmed speakers are Dr. Xavier Leroy, Dr. Brian Arey, and Dr. J. Silvio Gutkind.

Our data support a model wherein Smog regulates distinct myosin pools and actin cytoskeleton in a ligand-dependent

Our findings fill a gap in the understanding of CB1 allosteric regulation and could guide the rational

Our work demonstrates that differential subcellular signaling is critical to the overall biased response

Our final opsin phylogeny is the largest to date with 4956 opsins.

allosteric modulators have led to the identification of multiple allosteric sites and significantly enhanced our

Our results demonstrate the significance of incorporating membrane lipids as an integral component of

Current progress in our knowledge of the itch processing, the numerous mediators and receptors involved

Thus, our small-molecule-based fluorescent CCR2 ligand 14 represents a promising tool for future studies

Applied to HIV-1 envelope glycoproteins gp120, our quantitative analysis revealed agonist-like properties

Hello Readers👋, We're excited to share our weekly newsletter with you. Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news

Hello Readers👋, We're excited to share our weekly newsletter with you. Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news

bioinformatics and machine learning will play a pivotal role in addressing these obstacles, enhancing our structural biology techniques like X-ray crystallography and cryo-electron microscopy have deepened our

Hello Readers👋, We're excited to share our weekly newsletter with you. Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news

Our poster session is now a discussion on Kumospace. The GPCR Retreat is coming up November 2-4! Stay updated with our monthly Dr. GPCR Newsletter!

and allosteric modulation in angiotensin receptors: IUPHAR Review 34 "Functional advances have guided our

Our data demonstrate the molecular and functional interaction of VLGR1 with components in MAMs and point

Through our podcast, training programs, and partner content, we help scientists connect, collaborate,

Then, join us on September 22nd for our discussion session, formerly known as The poster session, on We'll be sharing the list of our confirmed speakers soon!

We are pleased to announce the scheduled dates for our highly anticipated courses led by Dr. As of July 31st, early-bird registration for our premium Ecosystem members will begin, allowing you to

Employing homology modeling, we describe the putative structural molecular basis underlying our functional

contributors to the immuno-suppressive tumor microenvironment, we incorporated the dynamics of TAMs into our

Check out our GPCR roundup now, and be the first to read! This week's highlights: Celebrating Dr. Kevin Wright on his new position as Director of Targeted and Immuno-oncology at GPCR Therapeutics, our

To our knowledge, this is the first report of a CNV in the ADGRL3 gene and its first association with

Welcome to our latest GPCR updates. This week's highlights: Dr. Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr.

Stay informed with our GPCR roundup. Our poster session is now an engaging Kumospace discussion.

Our approach, described in detail here, uses adeno-associated viruses infused intracerebrally in order

Dive into our GPCR coverage for this week! GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Only

GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Showcase™ 2024 Establishing our

Together with previously published S1PR structures in complex with antagonists and agonists, our structure